This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

InterCure Secures NIS 22 Million Private Placement to Fund Global Medical Cannabis Expansion

Tipranks - Tipranks - Tue Jun 23, 8:50AM CDT

TipRanks' Prime Week Sale - 70% Off

Intercure ( (IL:INCR) ) has issued an announcement.

On June 22, 2026, InterCure announced it had signed a binding term sheet with investors for a private placement of about NIS 22 million, or roughly US$7–7.4 million, with the potential to rise to NIS 54 million if attached warrants are fully exercised. The deal covers the issue of 7.9 million ordinary shares at a premium to the Tel Aviv market price plus five-year warrants, and includes participation from CEO Alexander Rabinovich and pharma-focused hedge funds such as Bennu Pharma Fund, with closing subject to definitive agreements and certain approvals.

Management framed the funding as a key step in InterCure’s recovery and growth strategy after war-related disruptions, saying the proceeds will bolster its balance sheet, support the recovery and expansion of its Nir Oz facility, and help meet rising demand in Israel, Germany and other regulated medical cannabis markets. The placement, conducted without underwriters and backed by existing shareholders and institutional investors, underscores continued confidence in InterCure’s market position and is intended to position the company for a return to sustainable growth and profitability.

More about Intercure

InterCure Ltd., operating as Canndoc, is a leading and profitable medical cannabis company listed on Nasdaq and TASE and based in Israel. Through its subsidiary Canndoc, it is the country’s largest licensed cannabis producer, supplying GMP-certified, pharmaceutical-grade products via a vertically integrated seed-to-sale model focused on Israel and fast-growing global medical cannabis markets.

Average Trading Volume: 57,611

Technical Sentiment Signal: Sell

Current Market Cap: ILs159.8M

For an in-depth examination of INCR stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Trending Articles

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).